USRE35609EExpiredUtility
Process for purifying 2',3'-dideoxynucleosides
Est. expiryJun 16, 2007(expired)· nominal 20-yr term from priority
Y10S435/822C12P 19/02C12P 19/38
28
PatentIndex Score
0
Cited by
11
References
16
Claims
Abstract
A biological process for producing a 2',3'-dideoxynucleoside from 2',3'-dideoxyuridine is disclosed. The 2',3'-dideoxynucleoside can be purified readily using a porous nonpolar resin absorbent.
Claims
exact text as granted — not AI-modifiedWhat is claimed as new and desired to be secured by Letters Patent of the United States is:
1. A process for the purification of a 2',3'-dideoxynucleoside from a solution obtained from a process requiring a microorganism or an enzyme, said solution containing, as impurities, other 2',3'-dideoxynucleosides or nucleic acid bases, said process comprising: (i) contacting said solution with a porous, nonpolar resin to cause the adsorption of said 2',3'-dideoxynucleoside onto said porous nonpolar resin, wherein said 2',3'-dideoxynucleoside is 2',3'-dideoxyadenosine or 2',3'-dideoxyinosine; (ii) separating said porous nonpolar resin from said solution; and (iii) fractionally eluting said adsorbed 2',3'-dideoxynucleoside to obtain a purified 2',3'-dideoxynucleoside product.
2. The process of claim 1, wherein said porous nonpolar resin is a styrene-divinylbenzene resin.
3. The process of claim 1, wherein said porous nonpolar resin is a modified styrene-divinylbenzene resin.
4. The process of claim 1, wherein said 2',3'-dideoxynucleoside is 2',3'-dideoxyadenosine.
5. The process of claim 4, wherein said porous nonpolar resin is a styrene-divinylbenzene resin.
6. The process of claim 4, wherein said porous nonpolar resin is a modified styrene-divinylbenzene resin.
7. The process of claim 1, wherein said 2',3'-dideoxynucleoside is 2',3'-dideoxyinosine.
8. The process of claim 7, wherein said porous nonpolar resin is a styrene-divinylbenzene resin.
9. The process of claim 7, wherein said porous nonpolar resin is a modified styrene-divinylbenzene resin.
10. The process of claim 1, said solution containing, as impurities, said other 2',3'-dideoxynucleosides and said nucleic acid bases.
11. The process of claim 4, said solution containing, as impurities, uracil and 2',3'-dideoxyuridine.
12. The process of claim 7, said solution containing, as impurities, uracil and 2',3'-dideoxyuridine.
13. The process of claim 4, said solution containing, as impurities, adenine, uracil and 2',3'-dideoxyuridine.
14. The process of claim 7, said solution containing, as impurities, uracil, 2',3'-dideoxyuridine and hypoxanthine.
15. The process of claim 4, said solution containing, as impurities, adenine.
16. The process of claim 7, said solution containing as impurities, hypoxanthine.Join the waitlist — get patent alerts
Track USRE35609E — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.